Assuming the high prevalence, in stage II and III, of microsatellite instability (MSI) in KRAS-mutated colon cancer, the evaluation of both BRAF and KRAS mutations in MSI colon cancers is useful for prognosis. The gene discussed is KRAS; the disease is malignant colon neoplasm.